Altering intensive care sedation paradigms to improve patient outcomes

Anesthesiology Clinics

Volumn 29, Issue 4, 2011, Pages 663-674

  Riker, Richard R ^a,b   Fraser, Gilles L ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAINE MEDICAL CENTER   (United States)

Author keywords

Adults; Analgesia; Critical care; Delirium; Outcomes; Sedation

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; BENZODIAZEPINE DERIVATIVE; DEXMEDETOMIDINE; LORAZEPAM; MIDAZOLAM; PROPOFOL; PROPYLENE GLYCOL; SEDATIVE AGENT;

ALGORITHM; ANALGESIA; BRADYCARDIA; BREATHING; CLINICAL PRACTICE; COGNITIVE DEFECT; DEATH; DELIRIUM; DRUG CHOICE; DRUG INDUCED DISEASE; HEART ARRHYTHMIA; HEART BUNDLE BRANCH BLOCK; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOTENSION; INTENSIVE CARE; INTENSIVE CARE UNIT; KIDNEY FAILURE; LACTIC ACIDOSIS; LIVER DYSFUNCTION; METABOLIC ACIDOSIS; OUTCOMES RESEARCH; PAIN; PANCREATITIS; RESPIRATION DEPRESSION; REVIEW; RHABDOMYOLYSIS; SEDATION; SIDE EFFECT; TACHYCARDIA; WAKEFULNESS;

EID: 81055131687     PISSN: 19322275     EISSN: 22103538     Source Type: Journal    
DOI: 10.1016/j.anclin.2011.09.006     Document Type: Review

References (75)

1. Ramsay M.A., Savege T.M., Simpson B.R., et al. Controlled sedation with alphaxalone-alphadolone. Br Med J 1974, 2(5920):656-659.
2. Merriman H.M. The techniques used to sedate ventilated patients. A survey of methods used in 34 ICUs in Great Britain. Intensive Care Med 1981, 7(5):217-224.
3. Simpson P.J., Eltringham R.J. Lorazepam in intensive care. Clin Ther 1981, 4(3):150-163.
4. Edbrooke D.L., Newby D.M., Mather S.J., et al. Safer sedation for ventilated patients. A new application for etomidate. Anaesthesia 1982, 37(7):765-771.
5. Ledingham I.M., Watt I. Influence of sedation on mortality in critically ill multiple trauma patients. Lancet 1983, 1(8336):1270.
6. Parker M.M., Schubert W., Shelhamer J.H., et al. Perceptions of a critically ill patient experiencing therapeutic paralysis in an ICU. Crit Care Med 1984, 12(1):69-71.
7. Ball M., McQuay H.J., Moore R.A., et al. Renal failure and the use of morphine in intensive care. Lancet 1985, 1(8432):784-786.
8. Shapiro J.M., Westphal L.M., White P.F., et al. Midazolam infusion for sedation in the intensive care unit: effect on adrenal function. Anesthesiology 1986, 64(3):394-398.
9. Grounds R.M., Lalor J.M., Lumley J., et al. Propofol infusion for sedation in the intensive care unit: preliminary report. Br Med J (Clin Res Ed) 1987, 294(6569):397-400.
10. Geller E., Halpern P., Barzelai E., et al. Midazolam infusion and the benzodiazepine antagonist flumazenil for sedation of intensive care patients. Resuscitation 1988, 16(Suppl):S31-S39.
11. Segredo V., Matthay M.A., Sharma M.L., et al. Prolonged neuromuscular blockade after long-term administration of vecuronium in two critically ill patients. Anesthesiology 1990, 72(3):566-570.
12. Shapiro B.A., Warren J., Egol A.B., et al. Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Crit Care Med 1995, 23(9):1596-1600.
13. Jacobi J., Fraser G.L., Coursin D.B., et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002, 30(1):119-141.
14. Rhoney D.H., Murry K.R. National survey of the use of sedating drugs, neuromuscular blocking agents, and reversal agents in the intensive care unit. J Intensive Care Med 2003, 18(3):139-145.
15. Patel R.P., Gambrell M., Speroff T., et al. Delirium and sedation in the intensive care unit: survey of behaviors and attitudes of 1384 healthcare professionals. Crit Care Med 2009, 37(3):825-832.
16. Wunsch H., Kahn J.M., Kramer A.A., et al. Use of intravenous infusion sedation among mechanically ventilated patients in the United States. Crit Care Med 2009, 37(12):3031-3039.
17. Martin J., Franck M., Sigel S., et al. Changes in sedation management in German intensive care units between 2002 and 2006: a national follow-up survey. Crit Care 2007, 11(6):R124.
18. Martin J., Franck M., Fischer M., et al. Sedation and analgesia in German intensive care units: how is it done in reality? Results of a patient-based survey of analgesia and sedation. Intensive Care Med 2006, 32(8):1137-1142.
19. Shehabi Y., Botha J.A., Boyle M.S., et al. Sedation and delirium in the intensive care unit: an Australian and New Zealand perspective. Anaesth Intensive Care 2008, 36:1-9.
20. Mehta S., Burry L., Fischer S., et al. Canadian survey of the use of sedatives, analgesics, and neuromuscular blocking agents in critically ill patients. Crit Care Med 2006, 34(2):374-380.
21. Mehta S., Meade M.O., Hynes P., et al. A multicenter survey of Ontario intensive care unit nurses regarding the use of sedatives and analgesics for adults receiving mechanical ventilation. J Crit Care 2007, 22(3):191-196.
22. Mehta S., McCullagh I., Burry L. Current sedation practices: lessons learned from international surveys. Crit Care Clin 2009, 25(3):471-488.
23. Riker R.R., Picard J.T., Fraser G.L. Prospective evaluation of the sedation-agitation scale in adult ICU patients. Crit Care Med 1999, 27:1325-1329.
24. Sessler C.N., Gosnell M.S., Grap M.J., et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 2002, 166(10):1338-1344.
25. Ely E.W., Margolin R., Francis J., et al. Evaluation of delirium in critically ill patients: validation of the confusion assessment method for the intensive care unit (CAM-ICU). Crit Care Med 2001, 29(7):1370-1379.
26. Ely E.W., Inouye S.K., Bernard G.R., et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 2001, 286(21):2703-2710.
27. Bergeron N., Dubois M.J., Dumont M., et al. Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med 2001, 27(5):859-864.
28. Devlin J.W., Fong J.J., Schumaker G., et al. Use of a validated delirium assessment tool improves the ability of physicians to identify delirium in medical intensive care unit patients. Crit Care Med 2007, 35(12):2721-2724.
29. Puntillo K.A., White C., Morris A.B., et al. Patients' perceptions and responses to procedural pain: results from Thunder Project II. Am J Crit Care 2001, 10(4):238-251.
30. Gélinas C. Management of pain in cardiac surgery ICU patients: have we improved over time?. Intensive Crit Care Nurs 2007, 23(5):298-303.
31. Breen D., Karabinis A., Malbrain M., et al. Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: a randomised trial. Crit Care 2005, 9(3):R200-R210.
32. Dahaba A.A., Grabner T., Rehak P.H., et al. Remifentanil versus morphine analgesia and sedation for mechanically ventilated critically ill patients: a randomized double blind study. Anesthesiology 2004, 101(3):640-646.
33. Muellejans B., Lopez A., Cross M.H., et al. Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit: a randomized double-blind controlled trial. Critical Care 2004, 8:R1-R11.
34. Rozendaal F.W., Spronk P.E., Snellen F.F., et al. Remifentanil-propofol analgo-sedation shortens duration of ventilation and length of ICU stay compared to a conventional regimen: a centre randomised, cross-over, open-label study in the Netherlands. Intensive Care Med 2008, 35:291-298.
35. Muellejans B., Matthey T., Scholpp J., et al. Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomized, open-label, pharmacoeconomic trial. Critical Care 2006, 10:R91.
36. Treggiari M.M., Romand J.A., Yanez N.D., et al. Randomized trial of light versus deep sedation on mental health after critical illness. Crit Care Med 2009, 37(9):2527-2534.
37. Schweickert W.D., Pohlman M.C., Pohlman A.S., et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 2009, 373(9678):1874-1882.
38. Strøm T., Martinussen T., Toft P. A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial. Lancet 2010, 375(9713):475-480.
39. Bauer T.M., Ritz R., Haberthür C., et al. Prolonged sedation due to accumulation of conjugated metabolites of midazolam. Lancet 1995, 346(8968):145-147.
40. Spina S.P., Ensom M.H. Clinical pharmacokinetic monitoring of midazolam in critically ill patients. Pharmacotherapy 2007, 27(3):389-398.
41. Yahwak J.A., Riker R.R., Fraser G.L., et al. Determination of a lorazepam dose threshold for using the osmol gap to monitor for propylene glycol toxicity. Pharmacotherapy 2008, 28:984-991.
42. Nelsen J.L., Haas C.E., Habtemariam B., et al. A prospective evaluation of propylene glycol clearance and accumulation during continuous-infusion lorazepam in critically ill patients. J Intensive Care Med 2008, 23(3):184-194.
43. Pandharipande P.P., Pun B.T., Herr D.L., et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007, 298(22):2644-2653.
44. Pandharipande P., Shintani A., Peterson J., et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 2006, 104(1):21-26.
45. Pandharipande P., Cotton B.A., Shintani A., et al. Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J Trauma 2008, 65(1):34-41.
46. Mallow Corbett S., Montoya I.D., Moore F.A. Propofol-related infusion syndrome in intensive care patients. Pharmacotherapy 2008, 28(2):250-258.
47. Kam P.C.A., Cardone D. Propofol infusion syndrome. Anaesthesia 2007, 62:690-701.
48. Fong J.J., Sylvia L., Ruthazer R., et al. Predictors of mortality in patients with suspected propofol infusion syndrome. Crit Care Med 2008, 36:2281-2287.
49. Riker R.R., Shehabi Y., Bokesch P.M., et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009, 301(5):489-499.
50. Maldonado J, Wysong A, van der Starre P, et al. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics, in press.
51. Ruokonen E., Parviainen I., Jakob S.M., et al. Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical ventilation. Intensive Care Med 2009, 35(2):282-290.
52. Dasta J.F., Kane-Gill S.L., Pencina M., et al. A cost-minimization analysis of dexmedetomidine compared to midazolam for long-term sedation in the ICU. Crit Care Med 2010, 38(1):497-503.
53. Dasta J.F., Jacobi J., Sesti A.M., et al. Addition of dexmedetomidine to standard sedation regimens after cardiac surgery: an outcomes analysis. Pharmacotherapy 2006, 26(6):798-805.
54. Gélinas C., Fillion L., Puntillo K.A., et al. Validation of the critical-care pain observation tool in adult patients. Am J Crit Care 2006, 15(4):420-427.
55. Payen J.F., Bru O., Bosson J.L., et al. Assessing pain in critically ill sedated patients by using a behavioral pain scale. Crit Care Med 2001, 29(12):2258-2263.
56. Hopkins R.O., Jackson J.C. Long-term neurocognitive function after critical illness. Chest 2006, 130(3):869-878.
57. Milbrandt E.B., Angus D.C. Bench-to-bedside review: critical illness-associated cognitive dysfunction-mechanisms, markers, and emerging therapeutics. Crit Care 2006, 10(6):238.
58. Bergbom-Engberg I., Haljamäe H. Assessment of patients' experience of discomforts during respiratory therapy. Crit Care Med 1989, 17(10):1068-1072.
59. Payen J.F., Bosson J.L., Chanques G., et al. Pain assessment is associated with decreased duration of mechanical ventilation in the intensive care unit: a post Hoc analysis of the DOLOREA study. Anesthesiology 2009, 111(6):1308-1316.
60. Spies C., Macguill M., Heymann A., et al. A prospective, randomized, double-blind, multicenter study comparing remifentanil with fentanyl in mechanically ventilated patients. Intensive Care Med 2011, 37(3):469-476.
61. Kanazawa H., Okada A., Igarashi E., et al. Determination of midazolam and its metabolite as a probe for cytochrome P450 3A4 phenotype by liquid chromatography-mass spectrometry. J Chromatogr A 2004, 1031(1-2):213-218.
62. Laine G.A., Hossain S.M., Solis R.T., et al. Polyethylene glycol nephrotoxicity secondary to prolonged high-dose intravenous lorazepam. Ann Pharmacother 1995, 29(11):1110-1114.
63. Seay R.E., Graves P.J., Wilkin M.K. Comment: possible toxicity from propylene glycol in lorazepam infusion. Ann Pharmacother 1997, 31(5):647-648.
64. Reynolds H.N., Teiken P., Regan M.E., et al. Hyperlactatemia, increased osmolar gap, and renal dysfunction during continuous lorazepam infusion. Crit Care Med 2000, 28(5):1631-1634.
65. Merz T.M., Regli B., Rothen H.U., et al. Propofol infusion syndrome-a fatal case at a low infusion rate. Anesth Analg 2006, 103(4):1050.
66. Chukwuemeka A., Ko R., Ralph-Edwards A. Short-term low-dose propofol anaesthesia associated with severe metabolic acidosis. Anaesth Intensive Care 2006, 34(5):651-655.
67. Herr D.L., Sum-Ping S.T.J., England M. ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth 2003, 17(5):576-584.
68. Kress J.P., Pohlman A.S., O'Connor M.F., et al. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000, 342(20):1471-1477.
69. Brook A.D., Ahrens T.S., Schaiff R., et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 1999, 27(12):2609-2615.
70. Mehta S., Burry L., Martinez-Motta J.C., et al. A randomized trial of daily awakening in critically ill patients managed with a sedation protocol: a pilot trial. Crit Care Med 2008, 36(7):2092-2099.
71. Study NCT00675363. Available at: Clintrials.gov. Accessed September 23, 2011.
72. Peterson J.F., Pun B.T., Dittus R.S., et al. Delirium and its motoric subtypes: a study of 614 critically ill patients. J Am Geriatr Soc 2006, 54(3):479-484.
73. Skrobik Y., Ahern S., Leblanc M., et al. Protocolized intensive care unit management of analgesia, sedation, and delirium improves analgesia and subsyndromal delirium rates. Anesth Analg 2010, 111(2):451-463.
74. Girard T.D., Kress J.P., Fuchs B.D., et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 2008, 371(9607):126-134.
75. Jones C., Griffiths R.D., Slater T., et al. Significant cognitive dysfunction in non-delirious patients identified during and persisting following critical illness. Intensive Care Med 2006, 32(6):923-926.